- Home
- RA vs EMBC Comparison
RA vs EMBC Comparison
Compare RA & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RA
- EMBC
- Stock Information
- Founded
- RA 2016
- EMBC 1924
- Country
- RA United States
- EMBC United States
- Employees
- RA N/A
- EMBC N/A
- Industry
- RA Investment Managers
- EMBC Medical/Dental Instruments
- Sector
- RA Finance
- EMBC Health Care
- Exchange
- RA Nasdaq
- EMBC Nasdaq
- Market Cap
- RA 740.2M
- EMBC 753.0M
- IPO Year
- RA N/A
- EMBC N/A
- Fundamental
- Price
- RA $13.22
- EMBC $19.82
- Analyst Decision
- RA
- EMBC Buy
- Analyst Count
- RA 0
- EMBC 2
- Target Price
- RA N/A
- EMBC $19.00
- AVG Volume (30 Days)
- RA 280.8K
- EMBC 491.4K
- Earning Date
- RA 01-01-0001
- EMBC 02-07-2025
- Dividend Yield
- RA 14.73%
- EMBC 3.02%
- EPS Growth
- RA N/A
- EMBC 9.84
- EPS
- RA N/A
- EMBC 1.34
- Revenue
- RA N/A
- EMBC $1,123,100,000.00
- Revenue This Year
- RA N/A
- EMBC $1.77
- Revenue Next Year
- RA N/A
- EMBC $1.14
- P/E Ratio
- RA N/A
- EMBC $14.81
- Revenue Growth
- RA N/A
- EMBC 0.21
- 52 Week Low
- RA $11.89
- EMBC $9.93
- 52 Week High
- RA $17.32
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- RA 35.41
- EMBC 63.43
- Support Level
- RA $13.40
- EMBC $19.16
- Resistance Level
- RA $13.49
- EMBC $20.50
- Average True Range (ATR)
- RA 0.08
- EMBC 0.94
- MACD
- RA -0.03
- EMBC -0.07
- Stochastic Oscillator
- RA 0.00
- EMBC 35.16
About RA Brookfield Real Assets Income Fund Inc.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities (collectively, Real Asset Companies and Issuers). The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.
About EMBC Embecta Corp.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.